Page 5 | Certara

Blog

Beyond Approval: Using Model-Informed Strategies to Maximize the Value of ADCs

Discover how model-informed drug development for ADCs integrates modeling, clinical data, and real-world evidence to…

CertaraApril 28, 2026

Webinar

Allometric Approach in pharmacokinetics when and how to use it

Danielle PillsburyApril 28, 2026

Blog

From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development

Explore Certara’s insights from QSPC 2026, including virtual patients, regulatory adoption, AI in QSP, and…

CertaraApril 28, 2026

On-Demand Webinar

Compliance? Anywhere, anytime: Automated controlled substance detection and tariff classification at Merck KGaA

Learn how Merck KGaA automates controlled substance detection and HS classification to ensure global compliance…

CertaraApril 27, 2026

Conference

ACS Fall 2026

– – Booth

CertaraApril 27, 2026

Fact Sheet

DIDB® Concomitant Meds Navigator

Explore the Concomitant Meds Navigator withing DIDB - An evidence-based tool within DIDB that helps…

CertaraApril 27, 2026

Blog

3 Things You Should Know About ADaM Standards

Learn the key aspects of ADaM standards, including the difference between SDTM and ADaM and…

CertaraApril 27, 2026

Announcement

Certara Enables Discovery Scientists to Accelerate Therapeutic Peptide Discovery with New D360 version

Discover how D360 26.0 enhances peptide design, sequence analysis, and workflows to help scientists accelerate…

CertaraApril 23, 2026

Blog

Top 10 Benefits of Simcyp® Simulator for Drug Development

JTVCdGVhbV9qdW1wX2xpc3QlNUQ= April 23, 2026 Physiologically based pharmacokinetic (PBPK) modeling has evolved from an emerging methodology…

CertaraApril 23, 2026

Blog

ADC Dose Optimization: Applying Model-Informed Strategies in Development

Explore ADC dose optimization using model-informed strategies to balance efficacy and safety across antibody drug…

CertaraApril 22, 2026

Beyond Approval: Using Model-Informed Strategies to Maximize the Value of ADCs

Allometric Approach in pharmacokinetics when and how to use it

From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development

Compliance? Anywhere, anytime: Automated controlled substance detection and tariff classification at Merck KGaA

ACS Fall 2026

DIDB® Concomitant Meds Navigator

3 Things You Should Know About ADaM Standards

Certara Enables Discovery Scientists to Accelerate Therapeutic Peptide Discovery with New D360 version

Top 10 Benefits of Simcyp® Simulator for Drug Development

ADC Dose Optimization: Applying Model-Informed Strategies in Development

Newsletter sign up

Quick links

Solutions

Contact